Commercial insight into the pharma and biotech sector.
Global Market Analytics
EvaluatePharma focuses on those companies impacting the commercial market with comprehensive market coverage of listed companies above $50m Market Cap, including full product information and consensus forecasts; and private companies. Most importantly EvaluatePharma eliminates all double accounting to present the most accurate view of the global market.
- Standardized worldwide financial and forecast models for easy benchmarking
- Sales Analysis by Region, Company Rankings & Market Share, Product Sales Rankings & Market Share
- Unique search categories include Therapy Area, Pharma Class, EphMRA ATC code, Technology, Product & Generic Sales
- The most comprehensive historic sales data available from 1986 onwards viewable in over 20 currencies
- Largest catalogue of company disclosed product sales commentary and R&D project commentary
- Charts & MAT analysis provide insightful graphical representation of the latest sales data
- Full history of company M&A deals including deal value,dates and accounting treatment